These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 7751415)

  • 1. Hypertension in diabetic patients: an update of interventional studies to preserve renal function.
    Hoelscher DD; Weir MR; Bakris GL
    J Clin Pharmacol; 1995 Jan; 35(1):73-80. PubMed ID: 7751415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure].
    Bernadet-Monrozies P; Rostaing L; Kamar N; Durand D
    Presse Med; 2002 Nov; 31(36):1714-20. PubMed ID: 12467154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal protection and antihypertensive drugs: current status.
    Salvetti A; Mattei P; Sudano I
    Drugs; 1999 May; 57(5):665-93. PubMed ID: 10353294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antihypertensive drugs, dietary salt, and renal protection: how low should you go and with which therapy?
    Weir MR; Dworkin LD
    Am J Kidney Dis; 1998 Jul; 32(1):1-22. PubMed ID: 9669419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rational drug treatment of the hypertensive diabetic with nephropathy.
    Ritz E; Hasslacher C; Mann J
    J Diabet Complications; 1988; 2(4):171-4. PubMed ID: 2976760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Are all antihypertensive drugs renoprotective?].
    Wolf S; Risler T
    Herz; 2004 May; 29(3):248-54. PubMed ID: 15167950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Control of arterial pressure in diabetic nephropathy].
    Luño J; García de Vinuesa S
    Nefrologia; 2001; 21(3):240-5. PubMed ID: 11471304
    [No Abstract]   [Full Text] [Related]  

  • 8. Renal protection in hypertensive patients: selection of antihypertensive therapy.
    Wenzel RR
    Drugs; 2005; 65 Suppl 2():29-39. PubMed ID: 16398060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renoprotective effects of antihypertensive drugs.
    Preston RA
    Am J Hypertens; 1999 Jan; 12(1 Pt 2):19S-32S. PubMed ID: 10077416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can we further slow down the progression to end-stage renal disease in diabetic hypertensive patients?
    Bretzel RG
    J Hypertens Suppl; 1997 Mar; 15(2):S83-8. PubMed ID: 9218204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antihypertensive treatment for patients with hypertension and diabetes type II--current clinical research].
    Rajzer M; Kawecka-Jaszcz K; Wojciechowska W
    Przegl Lek; 2003; 60(2):111-5. PubMed ID: 12939858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Intensive control of arterial pressure prevents renal impairement in patients with diabetes mellitus].
    Makolkin VI
    Kardiologiia; 2009; 49(2):91-5. PubMed ID: 19254227
    [No Abstract]   [Full Text] [Related]  

  • 13. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
    Vogt L; Kocks MJ; Laverman GD; Navis G
    Minerva Med; 2004 Oct; 95(5):395-409. PubMed ID: 15467515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of blood-pressure-lowering treatment on outcome incidence in hypertension: 10 - Should blood pressure management differ in hypertensive patients with and without diabetes mellitus? Overview and meta-analyses of randomized trials.
    Thomopoulos C; Parati G; Zanchetti A
    J Hypertens; 2017 May; 35(5):922-944. PubMed ID: 28141660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differing effects of antihypertensive agents on urinary albumin excretion.
    Weir MR
    Am J Nephrol; 1996; 16(3):237-45. PubMed ID: 8739883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Target blood pressure attainment in diabetic hypertensive patients: need for more diuretics?
    Sweileh WM
    Int J Clin Pharmacol Ther; 2009 Jul; 47(7):434-8. PubMed ID: 19640349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antihypertensive treatment in patients with type-2 diabetes mellitus: what guidance from recent controlled randomized trials?
    Zanchetti A; Ruilope LM
    J Hypertens; 2002 Nov; 20(11):2099-110. PubMed ID: 12409940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood pressure lowering for the prevention and treatment of diabetic kidney disease.
    Thomas MC; Atkins RC
    Drugs; 2006; 66(17):2213-34. PubMed ID: 17137404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ESH-ESC guidelines for the management of hypertension.
    Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
    Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of mineralocorticoid receptor antagonists in patients with hypertension and diabetes mellitus: a systematic review and meta-analysis.
    Takahashi S; Katada J; Daida H; Kitamura F; Yokoyama K
    J Hum Hypertens; 2016 Sep; 30(9):534-42. PubMed ID: 26674759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.